These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 26859077)

  • 21. Concomitant appearance of trisomy 8 and isochromosome 17q in a Philadelphia-positive clone in a patient with chronic myeloid leukemia in chronic phase: an alarm for changing therapeutic strategy.
    Orciuolo E; Buda G; Galimberti S; Sordi E; Cervetti G; Petrini M
    Cancer Genet Cytogenet; 2007 Sep; 177(2):166-7. PubMed ID: 17854678
    [No Abstract]   [Full Text] [Related]  

  • 22. Isochromosome 17q; A Novel Finding in Myeloid Sarcoma.
    de Mel S; Lee J; Chua C; Chua SP; Gole L; Poon L; Li J; Ng SB; Liu TC; Chng WJ; Chee YL
    J Clin Exp Hematop; 2016; 56(2):130-134. PubMed ID: 27980303
    [No Abstract]   [Full Text] [Related]  

  • 23. SETBP1 mutation analysis in 944 patients with MDS and AML.
    Thol F; Suchanek KJ; Koenecke C; Stadler M; Platzbecker U; Thiede C; Schroeder T; Kobbe G; Kade S; Löffeld P; Banihosseini S; Bug G; Ottmann O; Hofmann WK; Krauter J; Kröger N; Ganser A; Heuser M
    Leukemia; 2013 Oct; 27(10):2072-5. PubMed ID: 23648668
    [No Abstract]   [Full Text] [Related]  

  • 24. Cytogenetic profile and outcome of a pediatric acute promyelocytic leukemia patient presenting with isolated isochromosome 17q in absence of RARA rearrangement.
    Jain H; Shetty D; Narula G; Moulik NR; Tembhare P; Patkar N; Subramanian PG; Banavali S
    Blood Cells Mol Dis; 2021 May; 88():102443. PubMed ID: 32414556
    [No Abstract]   [Full Text] [Related]  

  • 25. Clinicopathologic and molecular characterization of myeloid neoplasms harboring isochromosome 17(q10).
    Visconte V; Tabarroki A; Zhang L; Hasrouni E; Gerace C; Frum R; Ai J; Advani AS; Duong HK; Kalaycio M; Saunthararajah Y; Sekeres MA; His ED; Shetty S; Rogers HJ; Tiu RV
    Am J Hematol; 2014 Aug; 89(8):862. PubMed ID: 24796269
    [No Abstract]   [Full Text] [Related]  

  • 26. Prognostic impact of blast cell counts in dysplastic bone marrow disorders (MDS and CMML I) with concomitant fibrosis.
    Machherndl-Spandl S; Sega W; Bösmüller H; Germing U; Gruber Ch; Nachtkamp K; Reinecke P; Sperr WR; Wimazal F; Müllauer L; Sotlar K; Horny HP; Tüchler H; Valent P; Krieger O
    Ann Hematol; 2014 Jan; 93(1):57-64. PubMed ID: 24241126
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Isochromosome 5p and related anomalies: a novel recurrent chromosome abnormality in myeloid disorders.
    Herry A; Douet-Guilbert N; Morel F; Le Bris MJ; Guéganic N; Berthou C; De Braekeleer M
    Cancer Genet Cytogenet; 2010 Jul; 200(2):134-9. PubMed ID: 20620596
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Novel homo- and hemizygous mutations in EZH2 in myeloid malignancies.
    Makishima H; Jankowska AM; Tiu RV; Szpurka H; Sugimoto Y; Hu Z; Saunthararajah Y; Guinta K; Keddache MA; Putnam P; Sekeres MA; Moliterno AR; List AF; McDevitt MA; Maciejewski JP
    Leukemia; 2010 Oct; 24(10):1799-804. PubMed ID: 20724984
    [No Abstract]   [Full Text] [Related]  

  • 29. Molecular genetic biomarkers in myeloid malignancies.
    Matynia AP; Szankasi P; Shen W; Kelley TW
    Arch Pathol Lab Med; 2015 May; 139(5):594-601. PubMed ID: 25152312
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mutant molecules of interest in myeloproliferative neoplasms: introduction.
    Tefferi A
    Acta Haematol; 2008; 119(4):192-3. PubMed ID: 18566535
    [No Abstract]   [Full Text] [Related]  

  • 31. Isochromosome 17q in patients with myelodysplastic syndromes: six new cases.
    Xiao Z; Liu S; Yu M; Xu Z; Hao Y
    Haematologica; 2003 Jun; 88(6):714-5. PubMed ID: 12801850
    [No Abstract]   [Full Text] [Related]  

  • 32. Isochromosome i(17q) as a sole cytogenetic abnormality in a case of leukemic transformation from myelodysplastic syndrome (MDS)/myeloproliferative diseases (MPD).
    Nishida H; Ueno H; Park JW; Yano T
    Leuk Res; 2008 Aug; 32(8):1325-7. PubMed ID: 18164759
    [No Abstract]   [Full Text] [Related]  

  • 33. High-throughput mutational screening adds clinically important information in myelodysplastic syndromes and secondary or therapy-related acute myeloid leukemia.
    Karimi M; Nilsson C; Dimitriou M; Jansson M; Matsson H; Unneberg P; Lehmann S; Kere J; Hellström-Lindberg E
    Haematologica; 2015 Jun; 100(6):e223-5. PubMed ID: 25769547
    [No Abstract]   [Full Text] [Related]  

  • 34. [Aberrations of chromosome 5 in myeloid malignancies with complex chromosome abnormalities].
    Liu Q; Xu W; Zhu Y; Fan L; Qiu HR; Wang R; Qiao C; Li JY
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Dec; 16(6):1257-60. PubMed ID: 19099622
    [TBL] [Abstract][Full Text] [Related]  

  • 35. G-CSF priming, clofarabine, and high dose cytarabine (GCLAC) for upfront treatment of acute myeloid leukemia, advanced myelodysplastic syndrome or advanced myeloproliferative neoplasm.
    Becker PS; Medeiros BC; Stein AS; Othus M; Appelbaum FR; Forman SJ; Scott BL; Hendrie PC; Gardner KM; Pagel JM; Walter RB; Parks C; Wood BL; Abkowitz JL; Estey EH
    Am J Hematol; 2015 Apr; 90(4):295-300. PubMed ID: 25545153
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mapping of the breakpoints on the short arm of chromosome 17 in neoplasms with an i(17q).
    Scheurlen WG; Schwabe GC; Seranski P; Joos S; Harbott J; Metzke S; Döhner H; Poustka A; Wilgenbus K; Haas OA
    Genes Chromosomes Cancer; 1999 Jul; 25(3):230-40. PubMed ID: 10379869
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognosis of secondary acute myeloid leukemia is affected by the type of the preceding hematologic disorders and the presence of trisomy 8.
    Koh Y; Kim I; Bae JY; Song EY; Kim HK; Yoon SS; Lee DS; Park SS; Park MH; Park S; Kim BK
    Jpn J Clin Oncol; 2010 Nov; 40(11):1037-45. PubMed ID: 20587614
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Jumping translocations of the long arms of chromosome 1 in myeloid malignancies is associated with a high risk of transformation to acute myeloid leukaemia.
    Najfeld V; Tripodi J; Scalise A; Silverman LR; Silver RT; Fruchtman S; Hoffman R
    Br J Haematol; 2010 Nov; 151(3):288-91. PubMed ID: 20738298
    [No Abstract]   [Full Text] [Related]  

  • 39. Risk assessment in myelodysplastic syndromes and myelodysplastic/myeloproliferative neoplasms.
    Cazzola M
    Haematologica; 2011 Mar; 96(3):349-52. PubMed ID: 21357714
    [No Abstract]   [Full Text] [Related]  

  • 40. SETBP1 mutations occur in 9% of MDS/MPN and in 4% of MPN cases and are strongly associated with atypical CML, monosomy 7, isochromosome i(17)(q10), ASXL1 and CBL mutations.
    Meggendorfer M; Bacher U; Alpermann T; Haferlach C; Kern W; Gambacorti-Passerini C; Haferlach T; Schnittger S
    Leukemia; 2013 Sep; 27(9):1852-60. PubMed ID: 23628959
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.